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ABSTRACT
The effect of local application of autologous platelet-rich plasma (PRP) on bone healing in combination
with the use of titanium implants with 2 different surface configurations was investigated. PRP fractions
were obtained from venous blood sample of 6 goats and applied via gel preparation and subsequent
installation in the implant site or via dipping of the implant in PRP liquid before insertion. Thirty-six
implants (18 non-coated and 18 calcium phosphate (CaP) coated) were placed into the goat femoral
condyles (trabecular bone). The animals were sacrificed at 6 weeks after implantation, and implants with
surrounding tissue were processed for light microscopical evaluation. In addition to subjective de-
scription of the histological findings, histomorphometrical variables were also evaluated (the bone-
implant contact and the bone mass adjacent to the implant). Significantly more interfacial bone-to-implant
contact was observed for all 3 groups of CaP-coated implants and the titanium / liquid group (non-coated
implant with PRP liquid) than for the other 2 non-coated titanium groups (with PRP gel or without PRP).
The evaluation of the bone mass close to implant surface indicated that all the groups induced a significant
increase of the bone mass except the PRP gel groups. On the basis of the observations, it was concluded
that magnetron-sputtered CaP coatings can improve the integration of oral implants in trabecular bone.
The additional use of PRP did not offer any significant effect on the bone response to the CaP-coated
implants, whereas PRP in a liquid form showed a significant effect on bone apposition to roughened
titanium implants during the early post-implantation healing phase.
INTRODUCTION
A MAJOR ADVANCE IN DENTISTRY has been the replacementof lost natural teeth using oral implants. The predict-
ability and long-term success of oral implants are well
documented.1,2 On the other hand, the success rates have
been reported to vary between patients, and several factors,
such as implant design, implant surface, surgical technique,
bone type, and loading conditions, have been shown to
influence implant osseointegration.3 Numerous studies
have shown that the success rate of implants in local host
bone with poor osteo-regenerative potential is low.4 In view
of this, Lekholm and Zarb have described 4 types of bone
density (I-IV).5 The survival rate of oral implants placed into
type IV bone is dramatically lower than with the other
types.6 Furthermore, clinical experience has shown that
implant failure occurs at relatively early stages after surgery.
Considering the effect of implant surface characteristics
on the bone response,7 2 different categories of qualities can
be discerned: topography and physicochemistry. The topo-
graphic features of the implant surface are related to the
degree of surface roughness. Moderate values of surface
1Department of Periodontology and Biomaterials, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
2Department of Oral Maxillofacial Surgery, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.
TISSUE ENGINEERING
Volume 12, Number 9, 2006
# Mary Ann Liebert, Inc.
2555
roughness (Sa: 1–2 mm) evoke a greater bone response than
lower or higher values.7 The use of calcium phosphate (CaP)
coatings has also been shown to benefit the bone response
during the initial healing period after implant insertion.8
Various animal studies have proved that CaP-coated implants
show greater bone contact than non-coated implants.9,10
In addition to surface quality, growth factors can also
stimulate bone healing around implants. The effect of
osteoinductive factors like bone morphogenetic proteins
or transforming growth factor (TGF)-b has been a topic
of various experiments.11,12 The disadvantage of these
growth factors is that they are expensive and concerns
exists about their safety in human administration.13 Alter-
natively, platelet-rich plasma (PRP), which is a volume of
autogenous plasma that has a platelet concentration above
baseline, is a proven source of growth factors.14 Growth
factors released from platelets15 include platelet-derived
growth factor (PDGF), TGF-b, platelet-derived epidermal
growth factor (PDEGF), platelet-derived angiogenesis
factor (PDAF), insulin-like growth factor I (IGF-I), and
platelet factor 4 (PF-4). The positive effect of PRP is at-
tributed to the angio-genetic, cell-proliferative, and differ-
entiating influence of TGF-b and PDGF, which are present
in PRP in high concentrations.16 Because PRP is developed
from autologous blood, it is inherently safe and free
from transmissible diseases. This distinguishes it from re-
combinant growth factors that are not native.17 PRP has
been mainly used as a bone graft–enhancement material,
and thus there is limited evidence to support the use of PRP
in combination with dental implant placement.18,19
Furthermore, PRP is usually applied as a gel by mixing it
immediately before use with calcium chloride and bovine
thrombin. However, the use of bovine thrombin has been
reported to be associated with the development of antibodies
to factors V and XI, which can result in the risk of life-
threatening coagulopathies.20 Therefore, Dugrillon et al.
have proposed the formation of PRP gel by adding calcium
without using thrombin as activator.21
Therefore, the purpose of the present study was to in-
vestigate the effect of local application of autologous PRP
on the trabecular bone healing around oral implants with 2
different surface qualities: a CaP-coated surface and a non-
coated titanium surface with similar roughness. In addition,
PRP was applied in 2 ways: using a gel preparation by
mixing the PRP fraction with calcium chloride solution and
bovine thrombin followed by subsequent installation in the
implant site and dipping the implant into the PRP fraction
before its insertion without using any additional agent.
MATERIALS AND METHODS
Implant preparation
Thirty-six cylindrical, commercially pure titanium im-
plants with a diameter of 3.4 mm and a length of 9 mm were
used. They were grit-blasted with aluminum oxide parti-
cles, acid-etched with a mixture of hydrochloric acid and
sulfuric acid for 1 min, cleaned ultrasonically in iso-
propanol, and dried at 1008C. Subsequently, half of the
implants were provided with a thin CaP coating.
The CaP coatings were applied using a commercially
available radio frequency magnetron sputter deposition
system (Edwards ESM 100, Sussex, UK). The thickness of
the CaP sputter coating was 1 mm. After deposition, the
coated specimens were subjected to an additional heat
treatment for 2 h at 5508C.
The physicochemical analysis showed that the heat-
treated coatings had a crystalline apatite-like structure with
a calcium:phosphate ratio of 1.8:2.0. Surface roughness
measurements, using a universal surface tester (Innowep
GmbH, Wu¨rzburg, Germany), revealed that the roughness
value for the non-coated implants was 2.1 mm, whereas the
CaP-coated implants showed a roughness value of 2.3 mm.
Scanning electron microscopy revealed that the non-coated
titanium implants had a surface morphology with sharp
peaks, whereas the surface of the CaP-coated implants had
a smooth globular appearance (Fig. 1).
Finally, all implants were cleaned ultrasonically for
10 min to remove any loose particles and sterilized in an
autoclave.
Procedure of PRP preparation and application
The PRP fraction was obtained from venous blood
of goats 1 day before implant placement; 250 cm3 of
blood was drawn and centrifuged at a transfusion labora-
tory (SanQuin, Nijmegen, The Netherlands) in various
cycles.22 Finally, 7.5 mL of PRP suspension was obtained
(Table 1). Counting of the platelet concentration was also
performed (platelet count exceeding 800106/mL).
The final application of the PRP fraction was performed
using gel preparation and subsequent installation in the
implant site or dipping of the implant in PRP liquid before
insertion. The PRP gel was obtained at the time of surgery
by mixing the PRP fraction with 10% calcium chloride
solution and 300 IU of bovine thrombin (Fibriquick, Or-
ganon Teknika, Boxtel, The Netherlands). The PRP liquid
was used alone, without addition of any agent.
Animal model and implantation procedure
Six healthy, mature female Saanen goats, weighing about
60 kg, were used in this study. Before surgery, blood
samples were taken from the goats to ensure that they were
free of caprine arthritis encephalitis and caseous lymph-
adenitis. The goats were housed in a stable, and national
guidelines for care and use of laboratory animals were
observed. The surgical procedure was performed under
general anesthesia, which was induced using an intravenous
injection of pentobarbital and maintained using isoflurane
2% to 3% through a constant volume ventilator via an
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endotracheal tube. During surgery, the goats were con-
nected to a heart monitor.
They also received antibiotic prophylaxis to reduce
perioperative infection risk, as follows:
 During surgery: Albipen 15%, 3 mL/50 kg subcutane-
ously (sc)
 1 day after surgery: Albipen LA, 7.5 mL/50 kg sc
 3 days after surgery: Albipen LA, 7.5 mL/50 kg sc
The implants were inserted into the left and right distal
femoral condyles of the goat. For the insertion of the im-
plants, each animal was immobilized on its back, and its hind
legs were shaved, washed, and disinfected with povidone-
iodine. A longitudinal incision was made on the medial
surface of the left and right femur, and the medial condyle
was exposed. After exposure of the femoral condyle, 3 pilot
holes were drilled (1.6 mm), which were gradually widened
with different drills to the final diameter of the implant
(3.4 mm). The distance between the 3 drill holes was always
at least 1 cm. The bone preparation was performed with a
gentle surgical technique using a low rotational drilling
speed (maximum 450 rpm) and continuous internal cooling.
After bone preparation, the holes were irrigated with sterile
water. After press-fit insertion of the implants, the soft tis-
sues were closed in separate layers using resorbable Vicryl
3–0 sutures. Thirty-six implants were placed: 18 CaP-coated
and 18 non-coated implants. Each animal received 6 im-
plants: 3 CaP-coated implants in 1 femoral condyle and
3 non-coated implants in the other. Regarding the use of
PRP, PRP gel was applied in 2 goats, PRP liquid fraction via
dipping of the implant was applied in 2 other goats, and the
residual 2 goats did not receive any PRP application (control
group). This resulted in 6 different treatment groups:
(1) CaP-coated implants (CaP), (2) CaP-coated implantsþ
PRP liquid (CaP/liquid), (3) CaP-coated implantsþ PRP
gel (CaP/gel), (4) non-coated implants (titanium), (5) non-
coated implantsþ PRP liquid (titanium/ liquid), and (6) non-
coated implantsþ PRP gel (titanium/ gel).
Postoperatively, the animals were housed in a stable,
where they could move freely. The animals were sacrificed
at 6 weeks after implantation using an overdose of Nem-
butal, and the implants and surrounding tissue were re-
trieved for histological preparation.
Histological preparation
After sacrifice of the animals, the femoral distal condyles
were excised, and excess tissue was removed. Then, using
a diamond saw, the retrieved condyles were divided into
smaller specimens suitable for histological processing.
Each specimen included 1 implant with surrounding bone.
The samples were fixed in 4% formaldehyde. Subsequently,
they were dehydrated through a graded series of ethanol,
embedded in methylmethacrylate, and polymerized. Lon-
gitudinal, mid-implant, thin non-decalcified sections (10 mm)
were made with a modified diamond blade–sawing micro-
tome technique. The sections were stained with methylene
blue and basic fuchsin and examined for histological and
histomorphometrical evaluation.
Histological and histomorphometrical evaluation
The histological evaluation was performed using a light
microscope (Leica Microsystems GmbH, Wetzlar, Germany)
TABLE 1. VOLUME AND PLATELET CONCENTRATION
OF PLATELET-RICH PLASMA (PRP) HARVESTED
FROM EACH GOAT
Goat PRP volume Platelet count
1 7.5 mL 1200106/mL
2 7.5 mL 800106/mL
3 7.5 mL 1000106/mL
4 7.5 mL 800106/mL
5 7.5 mL 1000106/mL
6 7.5 mL 1200106/mL
FIG. 1. The final roughness value for the non-coated implants
was 2.1 mm (A), whereas the final roughness value for the calcium
phosphate–coated implants was 2.3 mm (B).
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and included a description of the observed tissue response.
In addition, microscopic images were projected with a
magnification of 1.6 on a color monitor, and a digital
image analysis software (Leica Qwin Pro-image analysis
system, Wetzlar, Germany) was used for the histomor-
phometrical measurements.
The histomorphometrical analysis consisted of:
(a) Bone contact percentage: The amount of bone contact
was defined as the percentage of implant length at which
there was direct bone-implant contact without inter-
vening soft tissue layer. The measurements were per-
formed along the whole length of the implant, excluding
the most apical part.
(b) Bone mass percentage: The bone mass was evaluated
as the percentage of bone present in 2 defined fields:
0–1 mm and 1–2 mm from the implant surface.
All measurements were performed for at least 3 sections
per implant, and the results were based on the average of
these measurements.
Statistical analysis
All measurements were statistically evaluated using
paired t-test for paired data or analysis of variance (AN-
OVA) and Tukey test for multiple comparisons of the
means of different groups. The method of Kolmogorov and
Smirnov was used to confirm that the data were sampled
from a Gaussian distribution. In case of ANOVA analysis,
the method of Bartlett tested the assumption that the stan-
dard deviations of the groups were equal. Differences were
considered statistically significant when p was< 0.05.
RESULTS
Experimental animals
None of the goats showed signs of weakness after retrieval
of blood before surgery. All goats had an uneventful post-
operative recovery, and their weight remained stable during the
experimental period. At sacrifice, no clinical signs of inflam-
mation or adverse tissue reactions could be seen. Radiographs
taken parallel to the long axis of the implant assured that the
implants were located in trabecular bone. Although 3 implants
appeared to be placed near the epiphyseal growth plate, this did
not hamper their histomorphometrical evaluation.
PRP preparation
The volumes of the PRP and platelet concentrations, as
harvested from each goat, are shown in Table 1. According
to this randomized study design, goat 1 and goat 4 received
implants without application of PRP. The PRP preparation
resulted in platelet concentrations ranging from 800 to
1200106 platelets/mL.
Histological evaluation
The light microscopical evaluation of the implants showed
an uneventful healing of all implants without any sign of
inflammatory response. In all sections, the marginal bone
was at the same level as the top of the implant. Occasionally,
coronal invasion of connective tissue along the implant
surface was observed in some sections of all 6 implant groups
but never exceeded 2 mm. Because the histomorphometrical
measurements were performed along the whole length of the
implant, the crestal resorption and connective tissue invasion
affected the bone contact percentage negatively. In most
sections, the drilling procedure appeared to be accurate. In a
limited number of sections, the drill hole was too long.
Therefore, the most apical part (bottom) of the implants was
excluded from the study. The damage caused by the drilling
procedure appeared to be limited, as characterized by the
absence of drilling debris or fractured bone particles.
CaP-coated implants without PRP (Fig. 2A)
The histological sections for all CaP-coated implants
revealed a uniform bone reaction. In the interfacial area,
new bone formation had occurred along the implant sur-
face, whereas marrow spaces of different volume had in-
terrupted this bone-implant contact. The bone was in close
contact with the cement surface, without any sign of in-
tervening fibrous tissue layer. The implants were never
associated with an inflammatory response.
CaP-coated implants with PRP liquid (Fig. 2B)
In the area directly adjacent to the implant, new bone
formation had occurred on the implant surface without any
evidence of a soft tissue layer. The surface of the implants
was almost completely covered with a thin layer of new
lamellar bone. At the implant-bone interface, remodeling
lacunas containing osteoblasts and bone marrow–like tissue
were clearly visible. Next to the implant, no accumulations
of inflammatory cells were seen.
CaP-coated implants with PRP gel (Fig. 2C)
No differences in healing response between this group
and the other 2 groups of CaP-coated implants were ob-
served. A tight contact existed between the newly deposited
bone and the CaP-coated surface. In the interfacial area,
new bone formation had occurred along the implant surface
without an intervening fibrous tissue layer. Again, large
marrow spaces that contained osteoblasts interrupted this
bone-implant contact. No macrophages or giant cells were
seen between the implant surface and surrounding bone.
Non-coated implants without PRP (Fig. 3A)
In this group as well, none of the non-coated titanium
implants showed an adverse bone reaction. In the interfa-
cial area, new bone formation occurred along the implant
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surface, whereas marrow spaces of different volumes had
interrupted this bone-implant contact. The newly formed bone
had mainly a lamellar structure. Similar to the other implant
groups, no inflammatory cells were seen in any section.
Non-coated implants with PRP liquid (Fig. 3B)
Bone-apposition and bone-remodeling lacunae with bone
marrow stromal cells in close contact with the implant
surface were observed. The bone was closely adapted to the
implant surface without any sign of fibrous tissue forma-
tion. The interfacial bone contact appeared to be more
pronounced than the other non-coated implants. The PRP
liquid had not evoked an inflammatory response.
Non-coated implants with PRP gel (Fig. 3C)
In almost all sections, a thin layer of new lamellar bone
covered the implant surface without any fibrous tissue in-
tervention. Although in some sections, residual amorphous
material, probably consisting of degraded PRP gel, occu-
pied the inter-trabecular bone voids, no inflammatory re-
action was observed.
Histomorphometrical evaluation
Percentage of bone contact: The results of the bone
contact measurements are listed in Table 2. The data show
that the highest average amount of bone contact (94%)
occurred for the CaP/liquid implants, whereas the titanium-
implant group showed the lowest amount (60%). Statistical
comparison of the bone contact percentages between the
individual implant groups and various treatment combina-
tions confirmed that
1. no significant differences existed in bone contact
percentage between the 3 CaP coated-implant groups
2. titanium / liquid implants showed a significantly higher
bone contact percentage than the other 2 titanium
implant groups
3. no significant differences existed in bone contact
percentage between the titanium /liquid and any CaP-
coated implant group
Percentage of bone mass: The results for the bone mass
measurements are also given in Table 2. The bone mass
was determined in 2 different zones: 0–1 mm and 1–2 mm
from the implant surface. The results show that the per-
centage of bone mass in the 0- to 1-mm zone ranged from
49% to 69%, whereas in the 1- to 2-mm zone, it ranged
from 34% to 55%.
Statistical analysis showed that in the 0- to 1-mm area all
the implant groups induced a similar bone mass except the
titanium and titanium/gel implants, which were surrounded
FIG. 2. Histological sections of the calcium phosphate–coated titanium implants (magnification 16): (A) without application
of platelet-rich plasma (PRP), (B) with the use of PRP liquid, (C) with the use of PRP gel. Color images available online at
www.liebertpub.com /ten.
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by a significantly lower amount of bone. Also, in the area
1 to 2 mm away from the implant surface, a lower mass
of bone surrounded the titanium group than the other
groups. Finally, statistical evaluation (paired t-test) of the
bone mass between the 2 zones in each group indicated
that, for the CaP-, CaP/liquid-, titanium-, and titanium/
liquid-implant groups, more bone mass ( p< 0.05) was
present in the 0- to 1-mm zone than in the 1- to 2-mm zone.
Only for the implants inserted in combination with the PRP
gel did the amount of bone mass not differ significantly
( p> 0.05) between the 2 zones.
DISCUSSION
The purpose of the present study was to evaluate the
effect of the surface quality (CaP coating and surface
TABLE 2. MEAN AND STANDARD DEVIATION OF THE PERCENTAGE OF BONE CONTACT (%) AND BONE MASS (%) ESTIMATED
IN TWO DIFFERENT ZONES 0–1 MM AND 1–2 MM FROM THE IMPLANT SURFACE
Group Treatment modality Bone contact (%)
Bone mass (%)
zone 0–1mm
Bone mass (%)
zone 1–2mm
Titanium Non-coated implant (no PRP) 60 9* 55 7§ 34 1#
Titanium / liquid Non-coated implantþ PRP liquid 79 11 69 4 51 7
Titanium / gel Non-coated implantþ PRP gel 62 11 49 8§ 47 4
CaP CaP-coated implant (no PRP) 83 4 62 4 43 7
CaP/liquid CaP-coated implantþ PRP liquid 94 4 66 7 46 1
CaP/gel CaP-coated implantþ PRP gel 81 10 63 9 55 8
Six separate study groups were created based on the different treatment modalities. Analysis of variance and Tukey-Kramer multiple comparisons test
were used for the statistical analysis.
*The statistical analysis revealed that the non-coated / platelet-rich plasma (PRP) and non-coated / PRP gel groups had significantly less bone contact
than the other groups (p< 0.05). No other difference was significant.
§The statistical analysis revealed that the bone density in the region of 0–1 mm from the implant was significantly lower in the non-coated / PRP and
non-coated / PRP gel groups than in all the other groups ( p< 0.05).
#The bone density in the region of 1–2 mm from the implant was significantly lower in the non-coated/PRP group than in the non-coated / PRP liquid
( p< 0.05) and calcium phosphate (CaP)/ PRP gel groups ( p < 0.01).
FIG. 3. Histological sections of the non-coated rough titanium implants (magnification 16): (A) without application of platelet-rich
plasma (PRP), (B) with the use of PRP liquid, (C) with the use of PRP gel. Color images available online at www.liebertpub.com /ten.
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roughness) in combination with the application of PRP on
the initial bone response after implant placement.
Non-coated and CaP-coated implants had an almost
similar roughness, yet scanning electron microscopy
revealed small differences in surface morphology. The
additional CaP coating caused these small differences.
The final effect of this disparity on the study outcome can
currently not be answered and requires further investiga-
tion. Perhaps for future studies, a solution for the surface
roughness discrepancy can be found by deposition of an
additional thin titanium coating on the roughened bulk
titanium implant.
Notwithstanding this limitation in study design, the his-
tological and histomorphometric evaluation demonstrated
that the application of a thin magnetron-sputtered CaP
coating (1- to 2-mm thickness) favored the early bone
response. Six weeks after implantation, a higher percent-
age of bone-implant contact was established for CaP-coated
implants than for the non-coated ones. These findings
corroborate previous studies with similar coated implants in
the same animal model.9,23
Furthermore, the results revealed that PRP liquid (with-
out any activation) favored the bone-implant contact for
the roughened titanium implants, because the PRP liquid
implant groups always showed a significantly higher per-
centage of bone contact than the other 2 titanium-implant
groups (PRP gel and control). Although there was also a
tendency toward greater bone contact for the CaP-coated
implants after the application of PRP liquid, this difference
was not statistically significant. On the other hand, no effect
of the use of PRP gel on bone contact percentage was
observed for CaP-coated or non-coated titanium implants.
A similar study by Zechner et al. in 2003 in a mini-pig
model also failed to show any statistically significant effect
of PRP gel on peri-implant bone formation after a 6-week
healing period.24 In another study, Weibrich et al. analyzed
the influence of PRP gel on bone regeneration around self-
tapping titanium screw implants inserted in the femoral
bone of rabbits.25 After a 4-week healing period, no ad-
vantageous effect on bone-implant contact rate was seen.
These results are in agreement with our findings about PRP
gel. An explanation for the difference in result between
PRP liquid and PRP gel might be the trauma caused during
the installation of the PRP gel. After putting the PRP gel in
place, the implant is forced into the implant cavity. PRP gel
has a viscous, jelly-like consistency, which can result in
additional pressure on the drill walls of the already tightly
fitting implant. As a consequence, the healing process at the
bone-implant interface might become disturbed. Support
for this hypothesis is found in the occurrence of degraded
remnants of PRP gel in the inter-trabecular bone voids
around the titanium/gel implants. This might also clarify
why Kim et al. also found a higher percentage of bone
contact 6 weeks after implant placement when using
PRP gel, because they used a peri-implant defect model
and not a press-fit technique for implant insertion.26 In
addition, it is an interesting histologic finding that remnants
of PRP gel were only found around titanium/gel implants
and not around the CaP implants. A possible explanation
is that the CaP coating may play a role in the faster deg-
radation of PRP gel. In a recent study,27 the authors sug-
gest that bio-ceramics may enhance macrophage activation.
For the bone mass measurements, the bone mass was
calculated into 2 separate zones of 0 to 1 mm and 1 to 2 mm
from the implant surface. Changes in the former zone can
be related to the surgical method and the materials that
were used, whereas changes in the latter zone may be re-
lated to the bone quality (density) of the implant prepara-
tion site. Comparison of the obtained data showed that the
0- to 1-mm zone around the titanium and titanium /gel
implants contained significantly less bone mass than the
other implants. Furthermore, the results revealed greater
bone density in the 0- to 1-mm zone than in the 1- to 2-mm
zone for all groups except for the implants inserted in
combination with the PRP gel. In this case, bone density
did not differ significantly ( p > 0.05) between the 2 zones.
An explanation for the difference in results obtained with
PRP gel might be the trauma caused during installation of
the gel; bone responds to mechanical injury by increasing
in volume and density. Slotte et al. estimated a 35% in-
crease in bone mass after implant placement in comparison
with control bony sites in a rabbit model with an 8-week
healing period.28 Similar results were obtained in our study,
because there was evidently a greater increase in bone
mass in the 0- to 1-mm zone than in the 1- to 2-mm zone.
Nevertheless, the measurements at a distance of 1 to 2 mm
revealed also that the amount of bone mass was not uniform
around all implant types. This variation in bone mass be-
tween the groups may be an indication of a difference in
bone density between the implant preparation sites, be-
tween experimental animals, or both. The femoral condyle
consists of 2 different sections—the epiphysis and the
metaphysis—which have a different bone density and con-
tain different cell populations, leading to different wound-
healing events after implantation. Still, the final effect
of PRP liquid and implant surface composition was
consistent.
CONCLUSIONS
The results of the present study confirmed that magne-
tron-sputtered CaP coatings can improve the integration of
oral implants in trabecular bone. The additional use of PRP
did not offer any significant effect on the bone response to
the CaP-coated implants, whereas PRP in a liquid form had
a significant effect on bone apposition to roughened tita-
nium implants during the early post-implantation healing
phase. Nevertheless, additional studies are necessary to
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elucidate the underlying phenomenon for this effect and
to determine whether this indeed can be attributed to
the PRP.
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